首页 > 最新文献

Cornea最新文献

英文 中文
Outcomes of Descemet Stripping Only Without Postoperative Use of Topical Rho-Associated Protein Kinase Inhibitors. 不在术后使用局部 Rho- 相关蛋白激酶抑制剂的情况下仅进行去斑剥离术的结果
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-06-28 DOI: 10.1097/ICO.0000000000003619
Britta P Gustavson, Nicolás Kahuam-López, Sonia N Yeung, Alfonso Iovieno

Purpose: Descemet stripping only (DSO) is a promising surgical option for select patients with Fuchs endothelial dystrophy (FED). There is growing support for the use of topical Rho-associated protein kinase inhibitors (ROCKi) to optimize DSO outcomes. However, in many settings, ROCKi are either unavailable or not approved to treat corneal diseases. This study sought to characterize patient outcomes after DSO in the absence of ROCKi and potentially broaden the settings where DSO can be offered to patients.

Methods: Single-center retrospective case series of 15 eyes/11 patients (66 years; 52-74) that underwent DSO, alone or combined with cataract surgery, by one surgeon between August 2020 and January 2023. Patients included in analyses had FED with central guttae, no clinical evidence of corneal edema, and a clinically healthy peripheral corneal endothelium.

Results: Mean follow-up time was 14 months (2-34). Fourteen of 15 eyes achieved corneal clearance (93.3%). Mean time to clearance was 8.5 weeks (3-23). Eleven eyes (73%) achieved corrected distance visual acuity of ≤0.2 with a significant postoperative improvement at 4 to 8 months ( P < 0.05) and sustained improvements at >12 months. No significant astigmatism was introduced by the procedure. Two eyes developed cystoid macular edema postoperatively. A trend toward earlier clearance was observed in the <65 years old group.

Conclusions: Despite a longer time to corneal clearance in this cohort compared with the few studies using ROCKi, the overall success rate and visual outcomes for the patients in our cohort supports the use of DSO in settings where ROCKi are not readily available.

目的:对于特定的福氏内皮营养不良症(FED)患者来说,单纯去骨瓣剥离术(DSO)是一种很有前景的手术选择。越来越多的人支持使用局部Rho相关蛋白激酶抑制剂(ROCKi)来优化DSO效果。然而,在许多情况下,ROCKi 要么无法使用,要么未被批准用于治疗角膜疾病。本研究旨在了解在没有 ROCKi 的情况下,角膜屈光手术后患者的治疗效果,从而扩大角膜屈光手术的适用范围:单中心回顾性病例系列:2020 年 8 月至 2023 年 1 月期间,一名外科医生对 15 眼/11 名患者(66 岁;52-74 岁)进行了 DSO(单独或与白内障手术联合)。纳入分析的患者均有FED,伴有中央角膜钙化,无角膜水肿的临床证据,角膜周边内皮细胞临床健康:平均随访时间为 14 个月(2-34 个月)。15 只眼睛中有 14 只实现了角膜清除(93.3%)。平均清除时间为 8.5 周(3-23 周)。11只眼睛(73%)的矫正远距离视力≤0.2,术后4至8个月视力显著提高(P < 0.05),超过12个月视力持续提高。术后无明显散光。两只眼睛术后出现囊样黄斑水肿。结论》中观察到较早消除囊样黄斑水肿的趋势:尽管与少数几项使用 ROCKi 的研究相比,本组患者角膜清除时间较长,但我们组患者的总体成功率和视觉效果都支持在没有 ROCKi 的情况下使用 DSO。
{"title":"Outcomes of Descemet Stripping Only Without Postoperative Use of Topical Rho-Associated Protein Kinase Inhibitors.","authors":"Britta P Gustavson, Nicolás Kahuam-López, Sonia N Yeung, Alfonso Iovieno","doi":"10.1097/ICO.0000000000003619","DOIUrl":"10.1097/ICO.0000000000003619","url":null,"abstract":"<p><strong>Purpose: </strong>Descemet stripping only (DSO) is a promising surgical option for select patients with Fuchs endothelial dystrophy (FED). There is growing support for the use of topical Rho-associated protein kinase inhibitors (ROCKi) to optimize DSO outcomes. However, in many settings, ROCKi are either unavailable or not approved to treat corneal diseases. This study sought to characterize patient outcomes after DSO in the absence of ROCKi and potentially broaden the settings where DSO can be offered to patients.</p><p><strong>Methods: </strong>Single-center retrospective case series of 15 eyes/11 patients (66 years; 52-74) that underwent DSO, alone or combined with cataract surgery, by one surgeon between August 2020 and January 2023. Patients included in analyses had FED with central guttae, no clinical evidence of corneal edema, and a clinically healthy peripheral corneal endothelium.</p><p><strong>Results: </strong>Mean follow-up time was 14 months (2-34). Fourteen of 15 eyes achieved corneal clearance (93.3%). Mean time to clearance was 8.5 weeks (3-23). Eleven eyes (73%) achieved corrected distance visual acuity of ≤0.2 with a significant postoperative improvement at 4 to 8 months ( P < 0.05) and sustained improvements at >12 months. No significant astigmatism was introduced by the procedure. Two eyes developed cystoid macular edema postoperatively. A trend toward earlier clearance was observed in the <65 years old group.</p><p><strong>Conclusions: </strong>Despite a longer time to corneal clearance in this cohort compared with the few studies using ROCKi, the overall success rate and visual outcomes for the patients in our cohort supports the use of DSO in settings where ROCKi are not readily available.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"1516-1521"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter Regarding: Artificial Endothelial Layer Implantation After Multiple Failed Keratoplasties. 关于:多次角膜移植失败后的人工内皮层植入术。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-16 DOI: 10.1097/ICO.0000000000003657
Sreehari Suresh
{"title":"Letter Regarding: Artificial Endothelial Layer Implantation After Multiple Failed Keratoplasties.","authors":"Sreehari Suresh","doi":"10.1097/ICO.0000000000003657","DOIUrl":"10.1097/ICO.0000000000003657","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e49"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications After Pediatric Penetrating Keratoplasty: An IRIS Registry Study. 小儿穿透性角膜移植术后的并发症:IRIS 注册研究。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-13 DOI: 10.1097/ICO.0000000000003656
Lyvia J Zhang, Reza Dana, Alice C Lorch, Tobias Elze, Joan W Miller, Thomas H Dohlman, Isdin Oke

Purpose: To describe the frequency of postoperative complications in children undergoing penetrating keratoplasty (PK).

Methods: This retrospective cohort study included pediatric patients (aged 0-18 years) in the Intelligent Research in Sight (IRIS) Registry who underwent primary PK between January 2013 and December 2020. Patients were identified using Current Procedure Terminology codes. Postoperative complications were identified using International Classification of Diseases Revision 9 and 10 codes and categorized as complications affecting the anterior segment (epithelial defect, infectious keratitis, neurotrophic keratitis, and glaucoma) or posterior segment (vitreous hemorrhage, retinal detachment, choroid detachment, choroidal hemorrhage, endophthalmitis, epiretinal membrane, and proliferative vitreoretinopathy).

Results: Of the 544 pediatric patients undergoing PK, 259 (47.6%) experienced postoperative complications. Anterior segment complications (n = 222, 40.8%) were more common than posterior segment complications (n = 96, 17.6%). The most common anterior complication was infectious keratitis (n = 163, 30.0%) with a median onset time of 275 days (IQR 50-560 days) after surgery. Vitreous hemorrhage (n = 52, 9.6%) and retinal detachment (n = 48, 8.8%) were the most common posterior segment complications.

Conclusions: Infectious keratitis was the most common postoperative complication in children undergoing PK. More complications occurred in the anterior segment (70%) of the eye as compared with the posterior segment (30%). These findings demonstrate the challenges associated with pediatric PK and may help guide postoperative monitoring and management.

目的:描述接受穿透性角膜移植术(PK)的儿童术后并发症的发生频率:这项回顾性队列研究纳入了视力智能研究(IRIS)注册中心在 2013 年 1 月至 2020 年 12 月期间接受初级 PK 手术的儿童患者(0-18 岁)。患者身份使用当前手术术语代码确定。术后并发症使用《国际疾病分类修订版》第9版和第10版代码进行识别,并分为影响前段(上皮缺损、感染性角膜炎、神经营养性角膜炎和青光眼)或后段(玻璃体出血、视网膜脱离、脉络膜脱离、脉络膜出血、眼底病、视网膜外膜和增殖性玻璃体视网膜病变)的并发症:在接受PK手术的544名儿童患者中,259人(47.6%)出现了术后并发症。前段并发症(222 例,40.8%)比后段并发症(96 例,17.6%)更常见。最常见的前段并发症是感染性角膜炎(n = 163,30.0%),中位发病时间为术后 275 天(IQR 50-560 天)。玻璃体出血(52 例,9.6%)和视网膜脱离(48 例,8.8%)是最常见的后节并发症:感染性角膜炎是接受PK手术的儿童最常见的术后并发症。与眼球后段(30%)相比,更多并发症发生在眼球前段(70%)。这些发现表明了与小儿PK相关的挑战,可能有助于指导术后监测和管理。
{"title":"Complications After Pediatric Penetrating Keratoplasty: An IRIS Registry Study.","authors":"Lyvia J Zhang, Reza Dana, Alice C Lorch, Tobias Elze, Joan W Miller, Thomas H Dohlman, Isdin Oke","doi":"10.1097/ICO.0000000000003656","DOIUrl":"10.1097/ICO.0000000000003656","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the frequency of postoperative complications in children undergoing penetrating keratoplasty (PK).</p><p><strong>Methods: </strong>This retrospective cohort study included pediatric patients (aged 0-18 years) in the Intelligent Research in Sight (IRIS) Registry who underwent primary PK between January 2013 and December 2020. Patients were identified using Current Procedure Terminology codes. Postoperative complications were identified using International Classification of Diseases Revision 9 and 10 codes and categorized as complications affecting the anterior segment (epithelial defect, infectious keratitis, neurotrophic keratitis, and glaucoma) or posterior segment (vitreous hemorrhage, retinal detachment, choroid detachment, choroidal hemorrhage, endophthalmitis, epiretinal membrane, and proliferative vitreoretinopathy).</p><p><strong>Results: </strong>Of the 544 pediatric patients undergoing PK, 259 (47.6%) experienced postoperative complications. Anterior segment complications (n = 222, 40.8%) were more common than posterior segment complications (n = 96, 17.6%). The most common anterior complication was infectious keratitis (n = 163, 30.0%) with a median onset time of 275 days (IQR 50-560 days) after surgery. Vitreous hemorrhage (n = 52, 9.6%) and retinal detachment (n = 48, 8.8%) were the most common posterior segment complications.</p><p><strong>Conclusions: </strong>Infectious keratitis was the most common postoperative complication in children undergoing PK. More complications occurred in the anterior segment (70%) of the eye as compared with the posterior segment (30%). These findings demonstrate the challenges associated with pediatric PK and may help guide postoperative monitoring and management.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"1555-1559"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter Regarding: One-Year Results of a Phase I/II Randomized, Double-Masked, Placebo-Controlled Study of Processed Amniotic Fluid Drops After PRK. 关于:角膜屈光手术后处理羊水滴剂的 I/II 期随机、双掩蔽、安慰剂对照研究的一年结果。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-23 DOI: 10.1097/ICO.0000000000003686
Xue Lei
{"title":"Letter Regarding: One-Year Results of a Phase I/II Randomized, Double-Masked, Placebo-Controlled Study of Processed Amniotic Fluid Drops After PRK.","authors":"Xue Lei","doi":"10.1097/ICO.0000000000003686","DOIUrl":"10.1097/ICO.0000000000003686","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e50-e51"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Recommendations for Corneal Refractive Surgery Patients With Inherited Bleeding Disorders. 针对患有遗传性出血性疾病的角膜屈光手术患者的围手术期建议。
IF 16.4 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-26 DOI: 10.1097/ICO.0000000000003631
Majid Moshirfar, Jonathon C Reynolds, Kayvon A Moin, Ming Y Lim, Isabella M Stoakes, Phillip C Hoopes

Purpose: To synthesize the current literature regarding patients with inherited bleeding disorders and suggest comprehensive evaluation and preoperative recommendations for these patients before undergoing corneal refractive surgery.

Methods: The literature search was conducted through PubMed, Embase, and Google Scholar databases for publications through January 4, 2024 for reports of ocular bleeding manifestations in patients with inherited bleeding disorders and reports of patients without a history of bleeding disorders who had intraoperative or postoperative hemorrhagic complications with corneal refractive surgery. Additional cases from the literature and a retrospective chart review at a corneal practice were obtained describing patients with inherited bleeding disorders who underwent corneal refractive surgery.

Results: Four articles were found detailing ocular bleeding manifestations in patients with inherited bleeding disorders who underwent ocular surgery other than corneal refractive surgery. Thirty articles were found detailing intraoperative and postoperative bleeding manifestations in patients without a history of inherited bleeding disorders who underwent corneal refractive surgery. Eight cases (3 patients from the literature search and 5 patients from a retrospective chart review) were found regarding patients with inherited bleeding disorders who underwent corneal refractive surgery.

Conclusions: For corneal refractive surgery with topical anesthesia, the perioperative risk and need for any hemostasis intervention in individuals with an inherited bleeding disorder depends on the type of disorder, status of preoperative factor level concentrations, or a prior history of bleeding. If required, clotting factor optimization should be tailored to each candidate on a case-by-case basis.

目的:综述有关遗传性出血性疾病患者的现有文献,为这些患者在接受角膜屈光手术前提供全面评估和术前建议:通过PubMed、Embase和Google Scholar数据库检索截至2024年1月4日的文献,以了解有关遗传性出血性疾病患者眼部出血表现的报道,以及无出血性疾病史的患者在角膜屈光手术中出现术中或术后出血并发症的报道。我们还从文献和角膜病诊所的回顾性病历中获取了其他病例,这些病例描述了接受角膜屈光手术的遗传性出血性疾病患者的情况:结果:发现有四篇文章详细描述了接受角膜屈光手术以外的眼部手术的遗传性出血性疾病患者的眼部出血表现。有 30 篇文章详细介绍了接受角膜屈光手术的无遗传性出血性疾病史患者的术中和术后出血表现。在接受角膜屈光手术的遗传性出血性疾病患者中发现了8例病例(3例来自文献检索,5例来自回顾性病历审查):对于采用局部麻醉的角膜屈光手术,遗传性出血性疾病患者的围手术期风险和是否需要止血干预取决于疾病类型、术前因子水平浓度状况或既往出血史。如果需要,应根据每个患者的具体情况对凝血因子进行优化。
{"title":"Perioperative Recommendations for Corneal Refractive Surgery Patients With Inherited Bleeding Disorders.","authors":"Majid Moshirfar, Jonathon C Reynolds, Kayvon A Moin, Ming Y Lim, Isabella M Stoakes, Phillip C Hoopes","doi":"10.1097/ICO.0000000000003631","DOIUrl":"10.1097/ICO.0000000000003631","url":null,"abstract":"<p><strong>Purpose: </strong>To synthesize the current literature regarding patients with inherited bleeding disorders and suggest comprehensive evaluation and preoperative recommendations for these patients before undergoing corneal refractive surgery.</p><p><strong>Methods: </strong>The literature search was conducted through PubMed, Embase, and Google Scholar databases for publications through January 4, 2024 for reports of ocular bleeding manifestations in patients with inherited bleeding disorders and reports of patients without a history of bleeding disorders who had intraoperative or postoperative hemorrhagic complications with corneal refractive surgery. Additional cases from the literature and a retrospective chart review at a corneal practice were obtained describing patients with inherited bleeding disorders who underwent corneal refractive surgery.</p><p><strong>Results: </strong>Four articles were found detailing ocular bleeding manifestations in patients with inherited bleeding disorders who underwent ocular surgery other than corneal refractive surgery. Thirty articles were found detailing intraoperative and postoperative bleeding manifestations in patients without a history of inherited bleeding disorders who underwent corneal refractive surgery. Eight cases (3 patients from the literature search and 5 patients from a retrospective chart review) were found regarding patients with inherited bleeding disorders who underwent corneal refractive surgery.</p><p><strong>Conclusions: </strong>For corneal refractive surgery with topical anesthesia, the perioperative risk and need for any hemostasis intervention in individuals with an inherited bleeding disorder depends on the type of disorder, status of preoperative factor level concentrations, or a prior history of bleeding. If required, clotting factor optimization should be tailored to each candidate on a case-by-case basis.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"1599-1607"},"PeriodicalIF":16.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141757649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter Regarding: Tomographic Predictors of Ectasia Development After Keratorefractive Surgery. 角膜屈光手术后发生外翻的断层扫描预测因素
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-06-26 DOI: 10.1097/ICO.0000000000003611
Mehrdad Mohammadpour, Mehdi Aminizade
{"title":"Letter Regarding: Tomographic Predictors of Ectasia Development After Keratorefractive Surgery.","authors":"Mehrdad Mohammadpour, Mehdi Aminizade","doi":"10.1097/ICO.0000000000003611","DOIUrl":"10.1097/ICO.0000000000003611","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e48"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141455795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic and Psychiatric Associations With Dry Eye in a Medicare Population. 医疗保险人群中干眼症的人口统计学和精神病学关联。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-03-07 DOI: 10.1097/ICO.0000000000003516
Gavin Li, Catalina Garzon, Janek Klawe, Esen Karamursel Akpek, Sumayya Ahmad

Purpose: The purpose of this study was to investigate the impact of demographic characteristics and psychiatric comorbidity on the prevalence of dry eye disease in the American geriatric population.

Methods: Data were collected from a 2011 nationwide sample of Medicare beneficiaries aged 65 years and older (N = 1,321,000). Age, sex, race/ethnicity, residential area, climate region, and income, along with psychiatric comorbidities including depression and anxiety, were collected. Multivariable logistic regression models were used to assess the relationship between demographic and psychiatric factors and the prevalence of dry eye disease.

Results: Among 21,059 patients with clinically significant dry eye, women had higher odds of having dry eye compared with men [odds ratio (OR) 2.03, 95% confidence interval (1.97-2.10)]. Asian and Native American patients had increased odds of having dry eye compared with White patients [OR 1.85 (1.69-2.02) and OR 1.51 (1.19-1.93)], while Black patients were less likely to have dry eye [OR 0.83 (0.79-0.87)]. Patients aged 75 to 84 years and 85+ were more likely to have dry eye compared with those aged 65 to 74 years [OR 1.49 (0.45-1.53) and OR 1.54 (1.48-1.60)]. Having both depression and anxiety were associated with higher odds of having dry eye [OR 2.38 (2.22-2.55)] compared with having depression alone [OR 1.95 (1.86-2.04)] or anxiety alone [OR 2.22 (2.10-2.35)].

Conclusions: Significant racial and regional disparities in dry eye prevalence were found. Psychiatric association with dry eye varied with age, sex, race, and residence region. Further research is needed to comprehend the underlying mechanisms, implications, and to address disparities in the diagnosis and management of dry eye.

目的:本研究旨在调查人口统计学特征和精神疾病合并症对美国老年人群干眼症患病率的影响:从 2011 年全国范围内 65 岁及以上的医疗保险受益人样本中收集数据(样本数 = 1,321,000)。收集的数据包括年龄、性别、种族/民族、居住地区、气候区域和收入,以及包括抑郁和焦虑在内的精神疾病合并症。采用多变量逻辑回归模型评估人口和精神因素与干眼症患病率之间的关系:结果:在 21059 名有临床症状的干眼症患者中,女性比男性患干眼症的几率更高[几率比(OR)2.03,95% 置信区间(1.97-2.10)]。与白人患者相比,亚裔和美国原住民患者患干眼症的几率更高[OR 1.85 (1.69-2.02) 和 OR 1.51 (1.19-1.93)],而黑人患者患干眼症的几率较低[OR 0.83 (0.79-0.87)]。与 65 至 74 岁的患者相比,75 至 84 岁和 85 岁以上的患者更有可能患有干眼症[OR 1.49 (0.45-1.53) 和 OR 1.54 (1.48-1.60)]。与仅患有抑郁症[OR 1.95 (1.86-2.04)] 或仅患有焦虑症[OR 2.22 (2.10-2.35)]的人相比,同时患有抑郁症和焦虑症的人患干眼症的几率更高[OR 2.38 (2.22-2.55)]:结论:干眼症发病率在种族和地区之间存在显著差异。精神疾病与干眼症的关系因年龄、性别、种族和居住地区而异。要了解干眼症的潜在机制和影响,并解决干眼症诊断和管理中的差异问题,还需要进一步的研究。
{"title":"Demographic and Psychiatric Associations With Dry Eye in a Medicare Population.","authors":"Gavin Li, Catalina Garzon, Janek Klawe, Esen Karamursel Akpek, Sumayya Ahmad","doi":"10.1097/ICO.0000000000003516","DOIUrl":"10.1097/ICO.0000000000003516","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to investigate the impact of demographic characteristics and psychiatric comorbidity on the prevalence of dry eye disease in the American geriatric population.</p><p><strong>Methods: </strong>Data were collected from a 2011 nationwide sample of Medicare beneficiaries aged 65 years and older (N = 1,321,000). Age, sex, race/ethnicity, residential area, climate region, and income, along with psychiatric comorbidities including depression and anxiety, were collected. Multivariable logistic regression models were used to assess the relationship between demographic and psychiatric factors and the prevalence of dry eye disease.</p><p><strong>Results: </strong>Among 21,059 patients with clinically significant dry eye, women had higher odds of having dry eye compared with men [odds ratio (OR) 2.03, 95% confidence interval (1.97-2.10)]. Asian and Native American patients had increased odds of having dry eye compared with White patients [OR 1.85 (1.69-2.02) and OR 1.51 (1.19-1.93)], while Black patients were less likely to have dry eye [OR 0.83 (0.79-0.87)]. Patients aged 75 to 84 years and 85+ were more likely to have dry eye compared with those aged 65 to 74 years [OR 1.49 (0.45-1.53) and OR 1.54 (1.48-1.60)]. Having both depression and anxiety were associated with higher odds of having dry eye [OR 2.38 (2.22-2.55)] compared with having depression alone [OR 1.95 (1.86-2.04)] or anxiety alone [OR 2.22 (2.10-2.35)].</p><p><strong>Conclusions: </strong>Significant racial and regional disparities in dry eye prevalence were found. Psychiatric association with dry eye varied with age, sex, race, and residence region. Further research is needed to comprehend the underlying mechanisms, implications, and to address disparities in the diagnosis and management of dry eye.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"1499-1505"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Crystalline Corneal Opacities (Steroid Keratopathy) in Dogs After Treatment With Ophthalmic Corticosteroids. 狗狗在接受眼科皮质类固醇治疗后出现结晶性角膜翳(类固醇角膜病)。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-03-13 DOI: 10.1097/ICO.0000000000003523
Katelin R Quantz, Kamontip K Jongnarangsin, Christine D Harman, Kristin L Koehl, Amanda L Jacobson, Nambi Nallasamy, Gillian C Shaw, Christopher G Pirie, András M Komáromy

Purpose: To retrospectively evaluate and describe the relationship between the use of topical corticosteroids and the development of crystalline corneal opacities (steroid keratopathy) in a colony of research Beagles and Beagle-derived dogs.

Methods: Medical records of 73 purpose-bred Beagles and Beagle-derived dogs were reviewed from June 2012 to May 2021. All dogs were treated with topical ophthalmic corticosteroids for at least 21 days. In addition to regular ophthalmic examination, some dogs also had a systemic lipid profile (n = 6) performed to work up further and characterize the crystalline corneal opacities. Globes of 3 dogs were examined histopathologically.

Results: Axial stromal crystalline corneal opacities were appreciated in 25 eyes of 14 dogs after a median of 141 days after initiating treatment (35-396 days). Multiple corticosteroids were used, including neomycin-polymyxin b-dexamethasone 0.1% ophthalmic ointment, prednisolone acetate 1% ophthalmic suspension, and difluprednate 0.05% ophthalmic emulsion (Durezol). Resolution of corneal opacity was documented in 4 of 25 eyes when ophthalmic corticosteroids were discontinued after a median of 406.5 days (271-416 days). Histopathologic examination revealed a dense band of acellular material, poorly staining with periodic acid-Schiff, subtending the corneal epithelium, and being surrounded by spindle cells.

Conclusions: This case series documents the onset of steroid keratopathy in Beagles and Beagle-derived dogs after treatment with ophthalmic corticosteroids. Clinical resolution of steroid keratopathy lesions may be possible after discontinuation of ophthalmic corticosteroids.

目的:回顾性评估和描述研究用比格犬和比格犬衍生犬群中局部皮质类固醇的使用与结晶性角膜不透明(类固醇性角膜病)发生之间的关系:方法:研究人员回顾了 2012 年 6 月至 2021 年 5 月期间 73 只专门饲养的比格犬和比格犬衍生犬的医疗记录。所有狗狗都接受了至少 21 天的局部眼用皮质类固醇治疗。除了定期进行眼科检查外,有些狗还进行了全身血脂检查(n = 6),以进一步确定晶体角膜翳的特征。对 3 只狗的眼球进行了组织病理学检查:结果:在开始治疗后 141 天(35-396 天)的中位数时间内,14 只狗的 25 只眼睛出现了轴基质结晶性角膜翳。使用了多种皮质类固醇,包括 0.1% 新霉素-多粘菌素 b-地塞米松眼膏、1% 醋酸泼尼松龙眼用混悬液和 0.05% 双氟泼尼松酸钠眼用乳剂(Durezol)。在停用眼用皮质类固醇激素中位数为 406.5 天(271-416 天)后,25 只眼睛中有 4 只的角膜翳得到缓解。组织病理学检查显示,角膜上皮下有一条致密的无细胞物质带,定期酸-Schiff染色不佳,周围有纺锤形细胞:本系列病例记录了比格犬和比格犬衍生犬在接受眼部皮质类固醇治疗后发生类固醇角膜病的情况。停用眼用皮质类固醇后,类固醇性角膜病的病变可能会得到临床缓解。
{"title":"Development of Crystalline Corneal Opacities (Steroid Keratopathy) in Dogs After Treatment With Ophthalmic Corticosteroids.","authors":"Katelin R Quantz, Kamontip K Jongnarangsin, Christine D Harman, Kristin L Koehl, Amanda L Jacobson, Nambi Nallasamy, Gillian C Shaw, Christopher G Pirie, András M Komáromy","doi":"10.1097/ICO.0000000000003523","DOIUrl":"10.1097/ICO.0000000000003523","url":null,"abstract":"<p><strong>Purpose: </strong>To retrospectively evaluate and describe the relationship between the use of topical corticosteroids and the development of crystalline corneal opacities (steroid keratopathy) in a colony of research Beagles and Beagle-derived dogs.</p><p><strong>Methods: </strong>Medical records of 73 purpose-bred Beagles and Beagle-derived dogs were reviewed from June 2012 to May 2021. All dogs were treated with topical ophthalmic corticosteroids for at least 21 days. In addition to regular ophthalmic examination, some dogs also had a systemic lipid profile (n = 6) performed to work up further and characterize the crystalline corneal opacities. Globes of 3 dogs were examined histopathologically.</p><p><strong>Results: </strong>Axial stromal crystalline corneal opacities were appreciated in 25 eyes of 14 dogs after a median of 141 days after initiating treatment (35-396 days). Multiple corticosteroids were used, including neomycin-polymyxin b-dexamethasone 0.1% ophthalmic ointment, prednisolone acetate 1% ophthalmic suspension, and difluprednate 0.05% ophthalmic emulsion (Durezol). Resolution of corneal opacity was documented in 4 of 25 eyes when ophthalmic corticosteroids were discontinued after a median of 406.5 days (271-416 days). Histopathologic examination revealed a dense band of acellular material, poorly staining with periodic acid-Schiff, subtending the corneal epithelium, and being surrounded by spindle cells.</p><p><strong>Conclusions: </strong>This case series documents the onset of steroid keratopathy in Beagles and Beagle-derived dogs after treatment with ophthalmic corticosteroids. Clinical resolution of steroid keratopathy lesions may be possible after discontinuation of ophthalmic corticosteroids.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"1506-1515"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11393180/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140119002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply. 答复
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-05 DOI: 10.1097/ICO.0000000000003685
Jasmien Rens, Iva Krolo, Carina Koppen, Sorcha Ni Dhubhghaill
{"title":"Reply.","authors":"Jasmien Rens, Iva Krolo, Carina Koppen, Sorcha Ni Dhubhghaill","doi":"10.1097/ICO.0000000000003685","DOIUrl":"10.1097/ICO.0000000000003685","url":null,"abstract":"","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"e50"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142131999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic Characteristics, Clinical Presentations, and Risk Factors Impacting Visual Outcomes in Peripheral Ulcerative Keratitis. 外周溃疡性角膜炎患者的人口统计学特征、临床表现以及影响视觉效果的风险因素。
IF 1.9 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-12-01 Epub Date: 2024-03-14 DOI: 10.1097/ICO.0000000000003541
Rohan Bir Singh, Sarah Atta, Divya Srikumaran, Vishal Jhanji

Purpose: To assess the demographic characteristics, ophthalmic and systemic presentations, and risk factors impacting the outcomes in patients diagnosed with peripheral ulcerative keratitis (PUK).

Methods: This retrospective study includes patients diagnosed with PUK at a tertiary care center over 13 years. A descriptive analysis of the demographics, clinical history, and presentation was performed. A reverse risk analysis was performed to assess the PUK resolution in patients with underlying autoimmune and non-autoimmune etiologies. Finally, we evaluated the correlation between treatment duration and final best corrected visual acuity (BCVA) and continuous and categorical variables.

Results: A total of 58 eyes of 51 patients with a mean age of 59.67 ± 13.41 years diagnosed with PUK were included in the study; 58.82% were female. The resolution duration was significantly shorter in patients with autoimmune etiologies (vs. non-autoimmune etiologies, P = 0.028) and female patients (vs. male patients, P = 0.008). The BCVA worsened in patients with non-autoimmune etiologies after treatment ( P = 0.17). Despite worse BCVA at presentation in patients with underlying autoimmune etiologies, significantly better final vision outcomes were observed ( P = 0.04). Linear regression analysis showed that longer treatment duration ( P = 0.001; R 2 = 0.1704) and worse vision ( P = 0.002; R 2 = 0.1502) at presentation were the primary risk factors of poor vision outcomes. Similarly, the treatment duration was significantly longer in male compared with female patients ( P < 0.001; R 2 = 0.2027).

Conclusions: The clinical outcomes in PUK with underlying autoimmune disorders were observed to be better than non-autoimmune etiologies, which may be attributed to the early detection of the PUK-related changes and aggressive medical management. A delayed diagnosis of PUK leads to poor vision outcomes.

目的:评估被诊断为周围性溃疡性角膜炎(PUK)患者的人口统计学特征、眼部和全身表现以及影响预后的风险因素:这项回顾性研究包括 13 年来在一家三级医疗中心确诊的 PUK 患者。对人口统计学、临床病史和表现进行了描述性分析。我们还进行了反向风险分析,以评估潜在自身免疫和非自身免疫病因患者的 PUK 缓解情况。最后,我们评估了治疗时间与最终最佳矫正视力(BCVA)之间的相关性以及连续变量和分类变量:本研究共纳入了 51 名 PUK 患者的 58 只眼睛,患者平均年龄为(59.67 ± 13.41)岁,其中 58.82% 为女性。自身免疫性病因患者(与非自身免疫性病因患者相比,P = 0.028)和女性患者(与男性患者相比,P = 0.008)的缓解持续时间明显较短。治疗后,非自身免疫性病因患者的 BCVA 有所恶化(P = 0.17)。尽管有潜在自身免疫病因的患者发病时 BCVA 较差,但最终视力结果却明显更好(P = 0.04)。线性回归分析显示,治疗时间较长(P = 0.001;R2 = 0.1704)和发病时视力较差(P = 0.002;R2 = 0.1502)是视力不良的主要风险因素。同样,男性患者的治疗时间明显长于女性患者(P < 0.001; R2 = 0.2027):结论:与非自身免疫性病因相比,伴有潜在自身免疫性疾病的 PUK 的临床疗效更好,这可能归功于早期发现 PUK 相关病变和积极的医疗管理。PUK 诊断延迟会导致视力低下。
{"title":"Demographic Characteristics, Clinical Presentations, and Risk Factors Impacting Visual Outcomes in Peripheral Ulcerative Keratitis.","authors":"Rohan Bir Singh, Sarah Atta, Divya Srikumaran, Vishal Jhanji","doi":"10.1097/ICO.0000000000003541","DOIUrl":"10.1097/ICO.0000000000003541","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the demographic characteristics, ophthalmic and systemic presentations, and risk factors impacting the outcomes in patients diagnosed with peripheral ulcerative keratitis (PUK).</p><p><strong>Methods: </strong>This retrospective study includes patients diagnosed with PUK at a tertiary care center over 13 years. A descriptive analysis of the demographics, clinical history, and presentation was performed. A reverse risk analysis was performed to assess the PUK resolution in patients with underlying autoimmune and non-autoimmune etiologies. Finally, we evaluated the correlation between treatment duration and final best corrected visual acuity (BCVA) and continuous and categorical variables.</p><p><strong>Results: </strong>A total of 58 eyes of 51 patients with a mean age of 59.67 ± 13.41 years diagnosed with PUK were included in the study; 58.82% were female. The resolution duration was significantly shorter in patients with autoimmune etiologies (vs. non-autoimmune etiologies, P = 0.028) and female patients (vs. male patients, P = 0.008). The BCVA worsened in patients with non-autoimmune etiologies after treatment ( P = 0.17). Despite worse BCVA at presentation in patients with underlying autoimmune etiologies, significantly better final vision outcomes were observed ( P = 0.04). Linear regression analysis showed that longer treatment duration ( P = 0.001; R 2 = 0.1704) and worse vision ( P = 0.002; R 2 = 0.1502) at presentation were the primary risk factors of poor vision outcomes. Similarly, the treatment duration was significantly longer in male compared with female patients ( P < 0.001; R 2 = 0.2027).</p><p><strong>Conclusions: </strong>The clinical outcomes in PUK with underlying autoimmune disorders were observed to be better than non-autoimmune etiologies, which may be attributed to the early detection of the PUK-related changes and aggressive medical management. A delayed diagnosis of PUK leads to poor vision outcomes.</p>","PeriodicalId":10710,"journal":{"name":"Cornea","volume":" ","pages":"1528-1533"},"PeriodicalIF":1.9,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140130900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cornea
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1